Fundz
Back to Investors

Track EQT Life Sciences's Investment Activity

Get real-time alerts when EQT Life Sciences makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.

Compare PlansProFull access from $49/mo
E

EQT Life Sciences

Private Equity
eqtgroup.com/private-capital/eqt-life-sciences
Total Deals
31
Recent (90d)
2
Total Capital
$3.0B
Co-Investors
173
Pitch this inbox directly

Go to the EQT Life Sciences page on eqtgroup.com and scroll to the section headed "Do You Want to Submit an Investment Opportunity?". The button there opens an email to the team, so send your pitch that way; the address published for their dealflow is dealflow@eqtpartners.com. Send a short email with a deck or non confidential summary covering the science, stage, clinical data and how much you are raising. There is no online form, so a warm introduction from a portfolio founder or co investor still helps a lot.

eqtgroup.com/private-capital/eqt-life-sciences

dealflow@eqtpartners.com

Worth knowing. Checks run roughly 10 to 60 million euros, so pre seed and small seed rounds are out of range. They invest across three strategies (therapeutics, medtech and health tech growth) and are Europe centred with offices in Amsterdam, Munich and Boston, so a plain science story with no clinical or commercial traction is unlikely to clear the bar. Note this is the former LSP team inside EQT, not EQT Ventures, and reaching EQT Ventures will not get you to them.

How they invest
$80.0M
Median round they join
29
Companies backed
2
Checks in 90 days
Jul 28, 2026
Most recent check
Stages they write into
Series B 10Series A 7Series C 6Series D 4Funding Round 2

Built from 31 rounds we recorded since Mar 9, 2023.

Raising right now?

See every fund writing checks into companies like yours, ranked, each with a route in.

Build my investor list
X

Xeltis

ManufacturingSan Francisco, United States
venture - series unknown
$22.2M

Jul 28, 2026

R

RQ Bio

series a
$115.0M

Jun 24, 2026

N

Neurent Medical

Biotechnology
series c
$67.6M

Feb 12, 2026

T

Tenpoint Therapeutics

BiotechnologyLondon, United Kingdom
series b
$235.0M

Jan 29, 2026

E

Exciva

BiotechnologyStockholm, Sweden
series b
$55.1M

Jan 20, 2026

26+ more investments

View all 31 deals by EQT Life Sciences

ProFull deal history requires Pro

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity and website modifications, based on each user's watchlist and ICP. Trusted by firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz tracks 200,000+ companies and 40,000+ investors.

Fundz tracks 45,000 investors and their 13F holdings, alongside every round the companies they back raise.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.